Strategies for prevention of Clostridium difficile infection
- PMID: 22407995
- DOI: 10.1002/jhm.1908
Strategies for prevention of Clostridium difficile infection
Abstract
Infection control is the most essential component of an effective overall management strategy for prevention of nosocomial Clostridium difficile infection (CDI). The cornerstones of CDI prevention are appropriate contact precautions and strict hand hygiene. Other important tactics are effective environmental cleaning, identification and removal of environmental sources of C. difficile, and antibiotic stewardship. Hospitalists, as coordinators of care for each patient and advocates for quality care, can spearhead these efforts.
Copyright © 2012 Society of Hospital Medicine.
Similar articles
-
Preventing clostridium difficile infection in the intensive care unit.Crit Care Clin. 2013 Jan;29(1):11-8. doi: 10.1016/j.ccc.2012.10.006. Crit Care Clin. 2013. PMID: 23182524 Review.
-
Environmental interventions to control Clostridium difficile.Infect Dis Clin North Am. 2015 Mar;29(1):83-91. doi: 10.1016/j.idc.2014.11.006. Epub 2015 Jan 5. Infect Dis Clin North Am. 2015. PMID: 25573675 Review.
-
War on the spore: Clostridium difficile disease among patients in a long-term acute care hospital.J Healthc Qual. 2013 May-Jun;35(3):15-21. doi: 10.1111/j.1945-1474.2011.00182.x. Epub 2012 Feb 3. J Healthc Qual. 2013. PMID: 22304334
-
Hospital management of Clostridium difficile infection: a review of the literature.J Hosp Infect. 2015 Jun;90(2):91-101. doi: 10.1016/j.jhin.2015.02.015. Epub 2015 Mar 27. J Hosp Infect. 2015. PMID: 25913648 Review.
-
Prevention of Infection due to Clostridium (Clostridioides) difficile.Infect Dis Clin North Am. 2021 Dec;35(4):995-1011. doi: 10.1016/j.idc.2021.07.009. Infect Dis Clin North Am. 2021. PMID: 34752229 Review.
Cited by
-
Non-inferiority of pulsed xenon UV light versus bleach for reducing environmental Clostridium difficile contamination on high-touch surfaces in Clostridium difficile infection isolation rooms.J Med Microbiol. 2015 Feb;64(Pt 2):191-4. doi: 10.1099/jmm.0.000004-0. J Med Microbiol. 2015. PMID: 25627208 Free PMC article.
-
The Clinical Efficacy, Safety, and Tolerability of Vancomycin for the Treatment of Recurrent Clostridioides difficile Infection - A Systematic Review.Drug Healthc Patient Saf. 2023 Mar 21;15:63-71. doi: 10.2147/DHPS.S348501. eCollection 2023. Drug Healthc Patient Saf. 2023. PMID: 36974197 Free PMC article. Review.
-
Epidemiology and Pathogenesis of C. difficile and MRSA in the Light of Current NHS Control Policies: A Policy review.Ann Med Surg (Lond). 2012 Oct 6;1:39-43. doi: 10.1016/S2049-0801(12)70012-2. eCollection 2012. Ann Med Surg (Lond). 2012. PMID: 26257907 Free PMC article. Review.
-
A novel approach to correcting attribution of Clostridioides difficile in a healthcare setting.Antimicrob Steward Healthc Epidemiol. 2023 Dec 20;3(1):e246. doi: 10.1017/ash.2023.516. eCollection 2023. Antimicrob Steward Healthc Epidemiol. 2023. PMID: 38156213 Free PMC article.
-
Fidaxomicin's Role in Overcoming Vancomycin Failure in Clostridium difficile Infections: A Case Series and Literature Review.Cureus. 2025 Mar 24;17(3):e81110. doi: 10.7759/cureus.81110. eCollection 2025 Mar. Cureus. 2025. PMID: 40276451 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical